He Found the Opioid Fraud. He Reported It. Then He Was Fired and Then the Courts Shut Him Out.

EvilCorporations.com • Case No. 23-12985, U.S. Court of Appeals, Eleventh Circuit • 20 min read

The Non-Financial Ledger: What No Settlement Can Put Back

Picture working the emergency room of a small-city Alabama hospital for three years knowing, on some level, that what you are witnessing is wrong. You are a doctor. Your entire professional identity is built on the obligation to do no harm. But the institution around you has flipped that obligation upside down. The harm is the product. The harm is what gets billed. The opioid prescription is not a last resort; it is a revenue line.

Dr. Milner says he watched a fifth of the ER’s patients walk in and walk out with opioids. He described the Prattville ER as an “opiate den.” That is not a word a doctor uses lightly. That is a word a doctor uses when they have run out of clinical language for what they are seeing.

When he tried to push back, his superiors did not cite policy. They did not cite patient care protocols. According to Milner’s complaint, they told him to “give them a little something” to keep “the drug addicts and administration happy.” Read that again. Hospital management, in Milner’s account, described their own patients as “drug addicts” and named keeping those patients addicted as a management objective, in the same breath as keeping administration happy. The patients were a resource. Their dependency was a feature.

Milner was fired on December 18, 2017. Three days before Christmas. After that, he spent years in federal courts trying to hold these institutions accountable. He filed one lawsuit. It was dismissed. He filed another, specifically designed to recover money fraudulently taken from American taxpayers. That one was dismissed too, because of what happened in the first one.

The legal system did not find that Milner’s allegations were false. It did not rule that the fraud did not happen. It ruled that he had used the wrong procedural sequence when trying to expose it. The substance of the alleged $4 million per year billing fraud was never adjudicated on its merits. No court ever told Baptist Health, Prattville Baptist, or Team Health that what Milner described did or did not happen. The door was simply closed.

The patients who passed through that ER between 2014 and 2017 do not get a ruling either. They do not get acknowledgment. They do not get an apology. If the allegations are true, some of them received opioid prescriptions they did not need because a billing algorithm rewarded their doctor’s employer for writing those prescriptions. Some of them may have developed dependencies. Some of them may have carried those dependencies for the rest of their lives. None of that registers in a res judicata ruling.

The most brutal detail in this case is not the money. It is the mechanism. According to Milner, doctors who did not meet opiate prescription targets were punished. The institution built a system where the ethical choice, the clinical choice, the correct choice, had a professional cost. Every doctor in that ER was being trained, through consequences, to prescribe more opioids. The patients in front of them were not the primary consideration. The upcharge was.

Legal Receipts: What the Court Documents Actually Say

The following quotes come directly from the Eleventh Circuit’s opinion, filed March 31, 2025 (Case No. 23-12985). They are verbatim from the complaint allegations and court record as reproduced in the ruling. No paraphrasing.

“The Prattville ER was an opiate den with about twenty to twenty-five percent of visits involv[ing] opioids.”

— Milner’s Complaint, as cited in the Eleventh Circuit opinion, Page 3

• This is Milner’s own description from inside the ER. One in four patients leaving with an opioid prescription is not a clinical edge case. It is a pattern. And it is a pattern that, he alleges, was engineered by the billing structure.
• This allegation was never tested on its merits in court. The case was dismissed before any evidence could be examined. We do not know whether the rate is accurate. We know the courts chose not to find out.

“Team Health billed opioid visits and was able to increase health service charges and payments if the visit required opiates. This ‘upcharge’ practice resulted in the hospital getting paid and reimbursed for unnecessary visits.”

— Milner’s Complaint, as cited in the Eleventh Circuit opinion, Page 3

• This describes the core financial incentive: opioid prescriptions unlocked a higher billing tier. The prescription was not just a medical decision; it was a revenue event. Medicare and Medicaid, meaning federal and state taxpayers, funded the upcharge.
• Team Health is a national physician staffing company. It managed the doctors. The billing flowed through its structure. Milner’s allegation places the financial architecture at Team Health’s level, above the individual hospital floor.

“The hospital and emergency administration punishe[d] ER doctors who d[id] not meet opiate drug demands and show substantial upcharges related to opioid visits.”

— Milner’s Complaint, as cited in the Eleventh Circuit opinion, Page 3

• This is an allegation of an internal compliance system for opioid prescribing. Doctors who wrote fewer opioid prescriptions faced professional consequences. This is the mechanism that transforms individual physician decisions into institutional policy.
• If true, this means doctors who tried to follow evidence-based prescribing guidelines were punished. The system punished medical ethics.

“They have to keep the drug addicts and administration happy and [that] he should give them a little something.”

— Milner’s account of his superiors’ response when he raised concerns, Complaint as cited Page 3

• This is what Milner says administration told him when he tried to report the problem internally. The language is worth examining. His superiors, according to this account, described patients seeking opioids as “drug addicts” while simultaneously instructing Milner to prescribe to them. The patients’ dependency is acknowledged and exploited in the same sentence.
• “Administration happy” is placed on the same level as patient satisfaction. The institution’s financial performance and the patients’ pharmaceutical dependency are presented as equivalent management objectives.

“Milner’s attempts to ‘distinguish’ Ragsdale are really just attempts to convince this Court that Ragsdale was wrongly decided.”

— The Defendants’ argument, endorsed by the Eleventh Circuit, Page 10

• The court agreed with this framing. Its own hands were tied by a 1999 ruling. The Eleventh Circuit cannot change course without the full court sitting en banc. No en banc review is indicated in this ruling.
• Meanwhile, the Seventh Circuit (covering Illinois, Indiana, and Wisconsin) has already ruled the opposite: a personal retaliation suit should not kill a qui tam fraud recovery action. Two federal circuit courts, directly opposite holdings. Congress has not resolved this split.

The System That Was Supposed to Work: Compliance vs. Reality

The False Claims Act exists specifically for situations like this: a government contractor (here, a hospital billing Medicare and Medicaid) allegedly submits fraudulent claims, and a whistleblower from inside the organization tries to expose it. The law even rewards whistleblowers with a share of the recovery. Here is how the process was supposed to work, versus what actually unfolded.

Societal Impact Mapping: Who Pays When This Goes Unanswered

Public Health

The alleged opioid prescribing scheme at Prattville Baptist did not exist in a vacuum. It operated during the height of the American opioid crisis, using the same incentive structures that fueled overdose deaths across the country.

• Milner alleges that 20 to 25 percent of ER visits at the Prattville hospital involved opioid prescriptions. If that rate is accurate and reflected a billing-driven policy rather than clinical need, then a significant portion of patients received controlled substances they may not have required. Opioid dependency can develop from short-term prescriptions. ER visits are often the entry point.
• The alleged punishment of doctors who did not meet “opiate drug demands” created a structural pressure on all physicians at the facility. Every doctor in that ER faced a professional incentive to prescribe more and a professional disincentive to prescribe less. Patients seeking non-opioid pain management would have encountered doctors working inside that pressure system.
• Milner says he was fired on December 18, 2017, for raising the issue. His termination, if retaliatory, functioned as a message to every other physician at the facility: reporting this practice has a cost. The silencing of one internal critic protects the system from further challenge.
• The United States declined to intervene in Milner’s qui tam lawsuit in September 2022. That decision means no federal investigative resources were committed to examining the billing records, prescription patterns, or patient outcomes at this ER. The alleged public health harm was not pursued.

Economic Inequality

Medicare and Medicaid serve the country’s lowest-income and oldest residents. Fraudulent billing against these programs is a direct transfer of public money, money collected from workers in taxes, into private revenue. The alleged scale here is $4 million per year.

• Milner alleges that Team Health’s “upcharge” billing practice allowed the hospital to claim higher reimbursement rates when opioids were prescribed. This means the financial incentive was built directly into the government billing system. The more opioids prescribed to Medicaid and Medicare patients, the more the hospital collected from federal and state funds.
• Medicaid patients are disproportionately low-income. They are patients with the fewest resources to manage the downstream consequences of opioid dependency: addiction treatment, missed work, family disruption, legal problems. The alleged scheme targeted a billing system that serves the most vulnerable patients and extracted upcharge revenue from their visits.
• Milner’s qui tam lawsuit sought to recover funds on behalf of the United States government, not for himself alone. A successful qui tam action would have returned taxpayer money to the treasury. Because the case was dismissed on procedural grounds, that recovery was foreclosed. The alleged $4 million per year extraction was never subjected to a recovery proceeding on its merits.
• The legal doctrine that barred Milner, res judicata, is a rule that benefits defendants. It was applied here because Milner, acting without legal guidance sufficient to coordinate two simultaneous federal lawsuits with conflicting procedural requirements, filed his retaliation claim before his fraud recovery claim could survive. The procedural trap fell hardest on the person with the least institutional power in this case: the doctor who tried to report the problem.
• Team Health, a national physician staffing company, operates at scale across hundreds of hospitals. The resources available to its legal defense team in multiple federal court actions are structurally incomparable to those available to a single physician acting as a relator. The outcome of this case reflects that imbalance.

The “Cost of a Life” Metric

What Now? The Case Is Closed. The Fraud Question Is Not.

The Eleventh Circuit’s ruling on March 31, 2025 is final as to Dr. Milner’s ability to pursue this case. It does not resolve whether the fraud happened. Here is who still has power to act, and what you can do.

Corporate Actors Named in This Case

• Team Health — Physician staffing and billing entity. The complaint names Team Health as the entity that billed opioid visits and operated the upcharge structure. The court record identifies no individual executives by name.
• Baptist Health Montgomery — Hospital system, named defendant, operator of the Prattville facility during the alleged scheme period (2014–2017).
• Prattville Baptist — Named defendant, the specific hospital facility where the alleged prescribing patterns occurred.

Regulatory Watchlist

• Department of Justice (DOJ): The court’s ruling explicitly preserved the U.S. government’s right to bring its own FCA action against the defendants. The DOJ’s Civil Division handles Medicare/Medicaid fraud. If the government has not already investigated, a new referral is legally viable.
• Department of Health and Human Services Office of Inspector General (HHS-OIG): The OIG investigates Medicare and Medicaid fraud. Opioid billing upcharges fall squarely within its jurisdiction. HHS-OIG maintains a public fraud tip line.
• Drug Enforcement Administration (DEA): If controlled substances were systematically overprescribed for billing purposes, that conduct may implicate DEA regulations on opioid prescribing and distribution. The DEA has enforcement authority over prescription drug diversion.
• Centers for Medicare and Medicaid Services (CMS): CMS administers the billing systems that Milner alleges were defrauded. CMS can audit billing records, revoke provider enrollment, and refer cases for prosecution.
• Alabama State Board of Medical Examiners: State medical boards license physicians and can investigate prescribing patterns. If institutional pressure caused licensed physicians to prescribe opioids outside clinical standards, the state board has authority to investigate the facility’s influence on prescribing conduct.
• Congress: The circuit split between the Eleventh and Seventh Circuits on whether a failed retaliation suit bars a qui tam fraud action is a gap in federal law. Legislation clarifying FCA procedure would protect future whistleblowers from the procedural trap that closed this case.

What You Can Do Right Now

• Report Medicare and Medicaid fraud directly to the HHS Office of Inspector General: oig.hhs.gov/fraud/report-fraud. Tips are accepted anonymously. If you have knowledge of opioid billing fraud at any facility, this is the correct channel.
• Contact your congressional representatives and specifically ask them whether they support amending the False Claims Act to clarify that a failed retaliation claim does not bar a subsequent qui tam fraud action. The Seventh Circuit’s reasoning in Lusby v. Rolls-Royce is the legislative starting point.
• Support whistleblower protection organizations such as the Government Accountability Project (whistleblower.org) and the National Whistleblower Center. These organizations provide legal support to people in positions like Milner’s and advocate for legislative reforms that close procedural traps.
• If you are a healthcare worker who has witnessed similar prescribing incentive structures, document what you observe and consult with a False Claims Act attorney before taking any action. The procedural sequence matters enormously, as this case demonstrates.
• Local organizing: If you are in the Prattville or Montgomery, Alabama area, connect with the Alabama Arise advocacy network, which tracks healthcare access and Medicaid policy in the state. Community pressure on state-level Medicaid oversight is one avenue that federal court dismissals cannot close.